Skip to main content

Table 2 Infinium sensitivity and specificity

From: Using high-density DNA methylation arrays to profile copy number alterations

  Sensitivity
  Deletion Loss Gain Amplification
Chondrosarcoma 0.83 0.91 0.89 0.69
GBM 0.97 0.85 0.87 0.75
Bladder cancer 0.62 0.81 0.79 0.67
Prostate cancer 0.6 0.81 0.85 0.63
  1. The sensitivity and specificity of CNAs identified between SNP array and Infinium methylation arrays for four tumor types across a range of alteration types.